A new Alzheimer's disease prevention study has randomly assigned its first participant to a treatment group — a critical step known as randomization — helping researchers see if Alzheimer’s can be ...
Memory loss in Alzheimer's disease has long been viewed as an irreversible slide, but a new computational study suggests that ...
Every night, especially during deep sleep, your brain activates its glymphatic system to clear out waste. Here are ...
The P3 peptide, which has long been considered a relatively harmless protein processing product, may be involved in the ...
Alzheimer's disease affects tens of millions of people worldwide, and the World Health Organization estimates that over 55 ...
A neuroscientist built a model that scores zero on every benchmark. It made more of its users smarter than anything else she ...
Researchers were able to restore the function of neurons linked to cognitive function and information processing in mice that ...
BOSTON--Acta closes $24M in financing for Alzheimer’s disease pipeline targeting early intervention and prevention. Starts phase 1 study for GSM-779690T.
The test can spot the brain plaques that define Alzheimer’s long before a diagnosis would normally be on the table.
"Blood-based biomarkers have changed the diagnosis of Alzheimer’s disease faster than almost any test for older adults," says Richard Stefanacci, DO.
Microglial dysfunction is increasingly implicated in Alzheimer’s disease (AD) pathogenesis, with loss-of-function variants in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results